Shares of Zoetis have been roughly average performers over the past decade. The shares seem appealingly valued at recent ...

Despite Zoetis' underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish ...

These two stocks come from completely different industries, but each could boost a long-term investor's returns.

Hypnotic Video of GIGANTIC US Aircraft Carriers in the Middle of the Sea 'Alligator Alcatraz' migrant detention camp in ...

Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up ...

Zoetis Inc. Q2 2025 earnings highlight 8% organic revenue growth, raised guidance, and strong performance from Simparica and Key Dermatology franchises.

Zoetis (ZTS) stock surges premarket as the company posts strong Q2 2025 results and raises full-year outlook. Read more here.

Meanwhile, the company has an impeccable dividend program. The company has increased its payouts by 502% over the past decade ...

Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and ...

The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.62 per share. The animal health company posted revenue of $2.46 billion in the period, also topping ...

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2025 and raised its full year 2025 guidance.